Carney Fiona P, Nash Walter L, Sentell Karen B
CIBA Vision Corporation, 11460 Johns Creek Parkway, Duluth, GA 30097, USA.
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):120-4. doi: 10.1167/iovs.07-0376.
An in vitro study was conducted to measure the adsorption of major tear film lipids to soft contact lenses over time.
Commercial balafilcon A (PureVision; Bausch & Lomb, Rochester, NY), galyfilcon A (Acuvue Advance; Johnson & Johnson Vision Care), lotrafilcon A and B (Night & Day And O(2)Optix; CIBA Vision, Duluth, GA), senofilcon A (Acuvue Oasys; Johnson & Johnson Vision Care, Jacksonville, FL) and etafilcon A (Acuvue 2; Johnson & Johnson Vision Care) lenses were all soaked for 14 hours in the dark at 34.5 degrees C in either cholesterol (CH; nonpolar lipid) or phosphatidylethanolamine (PE; polar lipid), tagged with 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD) and N-fluorescein-5-thiocarbamoyl (FITC) labels, respectively. After rinsing, the lenses were measured for fluorescence and the corresponding lipid concentration was calculated from an appropriate standard curve. The lenses were then placed into a fresh 1-mL aliquot of the lipid being tested, and the procedure was repeated for 20 days.
In vitro adsorption of CH was greater that that of PE for all lens types (P < 0.0001 at days 14 and 20). After 20 days of soaking in PE, the lotrafilcon polymers showed the lowest adsorption of all the silicone hydrogel lenses tested at 0.4 and 1.5 microg/lens, for lotrafilcon A (P < or = 0.0001) and lotrafilcon B, respectively (P < or = 0.0001). Galyfilcon A and senofilcon A showed significantly higher PE adsorption at 5.1 and 4.9 microg/lens, respectively, compared with all other silicone hydrogel lenses investigated (P < 0.03). Senofilcon A (P < 0.0001) and balafilcon A (P < 0.02) had the highest affinity for CH of all the lens types after 20 days, with adsorptions of 23.2 and 24.1 microg/lens, respectively. Lotrafilcon B (P < 0.0001) showed the lowest in vitro adsorption of CH of all the lens types, at 3 mug/lens.
In vitro lipid adsorption varied greatly depending on the lens material for both polar and nonpolar lipids. Overall, there was less in vitro adsorption of lipid to the lotrafilcon A and B polymers than for any of the other silicone hydrogel polymers tested. The quantity of lipid adsorption by lotrafilcon polymers was similar to "conventional" hydrogel lenses.
进行一项体外研究,以测量主要泪膜脂质随时间在软性隐形眼镜上的吸附情况。
将市售的balafilcon A(PureVision;博士伦公司,纽约州罗切斯特)、galyfilcon A(Acuvue Advance;强生视力健公司)、lotrafilcon A和B(Night & Day And O(2)Optix;CIBA Vision公司,佐治亚州杜鲁斯)、senofilcon A(Acuvue Oasys;强生视力健公司,佛罗里达州杰克逊维尔)以及etafilcon A(Acuvue 2;强生视力健公司)镜片分别在34.5摄氏度黑暗环境中浸泡于用7-硝基苯并-2-恶唑-1,3-二氮杂萘-4-基(NBD)和N-荧光素-5-硫代氨基甲酰基(FITC)标记的胆固醇(CH;非极性脂质)或磷脂酰乙醇胺(PE;极性脂质)中14小时(此处原文有误,根据上下文推测应是20天)。冲洗后,测量镜片的荧光,并根据适当的标准曲线计算相应的脂质浓度。然后将镜片放入1毫升新鲜的待测脂质中,重复该过程20天。
对于所有类型的镜片,CH的体外吸附量均大于PE(第14天和20天时P < 0.0001)。在PE中浸泡20天后,lotrafilcon聚合物在所有测试的硅水凝胶镜片中吸附量最低(lotrafilcon A为0.4微克/镜片,lotrafilcon B为1.5微克/镜片),分别为(P ≤ 0.0001)和(P ≤ 0.0001)。与所有其他研究的硅水凝胶镜片相比,galyfilcon A和senofilcon A分别在5.1微克/镜片和4.9微克/镜片时显示出显著更高的PE吸附量(P < 0.03)。20天后,senofilcon A(P < 0.0001)和balafilcon A(P < 0.02)在所有镜片类型中对CH的亲和力最高,吸附量分别为23.2微克/镜片和24.1微克/镜片。lotrafilcon B(P < 0.0001)在所有镜片类型中CH的体外吸附量最低,为3微克/镜片。
对于极性和非极性脂质,体外脂质吸附因镜片材料不同而有很大差异。总体而言,lotrafilcon A和B聚合物的体外脂质吸附量低于任何其他测试的硅水凝胶聚合物。lotrafilcon聚合物的脂质吸附量与“传统”水凝胶镜片相似。